Among them, Lucentis® is the first anti-vascular endothelial growth factor (VEGF) drug approved for ophthalmic use in China, and has accumulated mature clinical application experience, providing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback